| Issue Date | Title | Author(s) |
| 2021-12-14 | Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability. | Burnett, DL; Jackson, KJL; Langley, DB; Aggrawal, A; Stella, AO; Johansen, MD; Balachandran, H; Lenthall, H; Rouet, R; Walker, G; Saunders, BM; Singh, M; Li, H; Henry, JY; Jackson, J; Stewart, AG; Witthauer, F; Spence, MA; Hansbro, NG; Jackson, C; Schofield, P; Milthorpe, C; Martinello, M; Schulz, SR; Roth, E; Kelleher, A; Emery, S; Britton, WJ; Rawlinson, WD; Karl, R; Schäfer, S; Winkler, TH; Brink, R; Bull, RA; Hansbro, PM; Jäck, H-M; Turville, S; Christ, D; Goodnow, CC |
| 2006-01 | Marked differences in the structures and protein associations of lymphocyte and monocyte CD4 Resolution of a novel CD4 isoform | Lynch, GW; Turville, S; Carter, B; Sloane, AJ; Chan, A; Muljadi, N; Li, S; Low, L; Armati, P; Raison, RL; Zoellner, H; Williamson, P; Cunningham, AL; Church, WB |
| 2022-11-15 | Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice. | Ashhurst, AS; Johansen, MD; Maxwell, JWC; Stockdale, S; Ashley, CL; Aggarwal, A; Siddiquee, R; Miemczyk, S; Nguyen, DH; Mackay, JP; Counoupas, C; Byrne, SN; Turville, S; Steain, M; Triccas, JA; Hansbro, PM; Payne, RJ; Britton, WJ |
| 2021-02-04 | SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays | Walker, GJ; Naing, Z; Stella, AO; Yeang, M; Caguicla, J; Ramachandran, V; Isaacs, SR; Agapiou, D; Bull, RA; Stelzer-Braid, S; Daly, J; Gosbell, IB; Hoad, VC; Irving, DO; Pink, JM; Turville, S; Kelleher, AD; Rawlinson, WD |
| 2020-12 | SARS-CoV-2 in human milk is inactivated by Holder pasteurisation but not cold storage. | Walker, GJ; Clifford, V; Bansal, N; Stella, AO; Turville, S; Stelzer-Braid, S; Klein, LD; Rawlinson, W |
